Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 4/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4636158 | 0.88 | ADORA1 (0.48) | ADORA1ADORA2AADORA2BHTR1AADORA3 | |
| SCHEMBL4636795 | 0.87 | ADORA1 (0.47) | ADORA1ADORA2AADORA2BHTR1AADORA3 | |
| SCHEMBL4637338 | 0.86 | ADORA2A (0.61) | ADORA1ADORA2AADORA2BHTR1AADORA3 | |
| SCHEMBL4636181 | 0.85 | ADORA2A (0.55) | ADORA1ADORA2AADORA2BHTR1AADORA3 | |
| SCHEMBL2534038 | 0.82 | ADORA2A (0.47) | ADORA1ADORA2AADORA2BMAOB | |
| SCHEMBL4636001 | 0.81 | MAOA (0.43) | ADORA1MAOB | |
| SCHEMBL2542959 | 0.81 | ADORA2A (0.43) | ADORA1ADORA2AADORA2B | |
| SCHEMBL4636790 | 0.80 | MAOB (0.47) | ADORA2AADORA2BMAOB | |
| SCHEMBL4637336 | 0.80 | ADORA2A (0.60) | ADORA1ADORA2AADORA2BHTR1AADORA3 | |
| SCHEMBL2542620 | 0.80 | MAOB (0.42) | ADORA1ADORA2AADORA2BMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1939197-A1 | 8-ethinylxanthine derivatives as selective A2A receptor antagonists | SCHWARZ PHARMA AG (DE) | 2008-07-02 | — | — | EP | disclosed |